Stroke is one of the DEVASTATING DISEASES, robbing people of their independence and their quality of life.

1 in 6 icon

1 in 6

People worldwide will have a 
stroke in their lifetime1

6 seconds icon

6 seconds

Worldwide, a stroke claims 
a life every 6 seconds1

stroke icon


Stroke remains the third
leading cause of death in the
 world and a leading cause
of long-term disability1







New CERENOVUS products coming soon! 

Please visit our booth at the major upcoming CONGRESSES in Europe for more information! 

Spectra Family of Coils

Spectra Family of Coils

Designed to treat aneurysms from start to finish

Learn More

NTI Image

Neuro Thromboembolic Initiative

The complex nature of clot can complicate therapeutic intervention.

No two occlusions are alike – clots that cause a stroke can have a variety of compositions and properties. The NTI is a commitment to advance the treatment of stroke through interdisciplinary collaboration and investment in clot and occlusion research.

Learn More

Let’s change the TRAJECTORY of stroke. We are committed to pushing the boundaries of what is possible in stroke care.

News & Events
cerenovus embotrap
New CERENOVUS study demonstrates cost-savings associated with First-Pass Effect in mechanical thrombectomy for treating acute ischemic stroke in the US and Europe
CERENOVUS Launches NIMBUS™ Geometric Clot Extractor to Remove Tough Clots
fighting stroke together hero image
Fighting Stroke Together
First Intracranial Aneurysm Patients Treated with BRAVO Flow Diverter Following European Regulatory Approval
First Intracranial Aneurysm Patients Treated with BRAVO Flow Diverter Following European Regulatory Approval

Limited warranty and disclaimer: CERENOVUS products are sold with a limited warranty to the original purchaser against defects in workmanship and materials. Any other express or implied warranties, including warranties of merchantability or fitness, are hereby disclaimed. Please also refer to the package insert(s) or other labeling associated with the devices identified in this document for additional information.
Not all products are licensed or available in all EMEA countries.

Note: For recognized manufacturer, refer to the product label.

For product details such as indications, contraindications, warnings and precautions please consult the IFU.

© CERENOVUS 2019. All Rights Reserved.
This site is published by Johnson & Johnson Medical Ltd. which is solely responsible for its content.
This site is for visitors from Europe, Middle East and Africa.
The third party trademarks used herein are trademarks of their respective owners.